Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04998175
Other study ID # 2020-796
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 15, 2020
Est. completion date December 30, 2022

Study information

Verified date September 2020
Source Second Affiliated Hospital, School of Medicine, Zhejiang University
Contact Junming Zhu, M.D.
Phone 86-13968055768
Email dr.zhujunming@zju.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The research is designed to study the prognostic factors of ventriculoperitoneal (VP) shunt for iNPH by multi-omics research


Description:

Preoperative T1-MRI, functional MRI and diffusion MRI imaging data of iNPH patients were collected. The clinical assessment was performed before/after the lumbar puncture test and 6 months after VP shunt. Clinical assessment included Mini-mental State Examination (MMSE), gait scores, Kiefer score, and Modified Rankin Scale (mRS). The cerebrospinal fluid was collected by tap-test, and 6 months after surgery by puncturing in the VP device pump. Methods- The primary methods used are: 1. The cerebrospinal fluid proteomic analysis of iNPH patients before and after VP shunt surgery. 2. The structral and functional MRI analysis of iNPH patients 3. The clinical assessment of MMSE, gait scores, Kiefer score, and mRS. Objective- To study the prognostic factors of VP shunt for iNPH.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 30, 2022
Est. primary completion date December 30, 2022
Accepts healthy volunteers No
Gender All
Age group 60 Years to 90 Years
Eligibility Inclusion Criteria: - Age = 60 years; - Diagnosis of iNPH based on clinical assessment - Participant is able to give written informed consent Exclusion Criteria: - Combining AD and Parkinson's disease and other nervous system diseases - Participant is not medically available for shunt surgery - Secondary NPH

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
ventriculo-peritoneal shunt
A ventriculoperitoneal shunt is a tube that drains excess cerebrospinal fluid into abdomen

Locations

Country Name City State
China The second affliated hospital of zhejiang university Hangzhou Zhejiang

Sponsors (2)

Lead Sponsor Collaborator
Second Affiliated Hospital, School of Medicine, Zhejiang University Westlake University

Country where clinical trial is conducted

China, 

Outcome

Type Measure Description Time frame Safety issue
Primary Proteomic pattern of CSF in iNPH patients Comparing the proteomic pattern differences in CSF between iNPH patients and normal age-matched normal volunteers by the analysis of mass spectrometry. Also, the responsive and non-responsive iNPH patients proteomic pattern were analzed. Before surgery in lumbar CSF
Primary Proteomic pattern changes of CSF in iNPH patients after VP shunt Comparing the proteomic pattern differences in CSF of iNPH patients before surgery and after VP shunt by the analysis of mass spectrometry. Also, the responsive and non-responsive iNPH patients proteomic pattern were analzed. Change from Baseline (ventricular CSF) at 6 months after VP shunt
Secondary Gray Matter Density Using automatic cortical and subcortical segmentation from the 3-dimensional T1weighted images to measure gray matter density in iNPH patients before surgery compared with healthy individual group. Also, the responsive and non-responsive iNPH patients structral MRI were analzed. Before surgery
Secondary Change in the resting state fMRI Change of BOLD singal intensity in the resting state fMRI in iNPH patients compared with normal healthy group. Also, the responsive and non-responsive iNPH patients functional MRI were analzed. Before surgery
Secondary White matter abnormity Franctional anisotropy, mean diffusivity and apparent diffusion coefficient were measured by diffusion MRI in region of interest of iNPH patients compared with normal healthy group. Also, the responsive and non-responsive iNPH patients diffusion MRI were analzed. Beore surgery
Secondary Kiefer score A score for iNPH severity; range 0-26; higher indicates higher severity. Change from Baseline at 6 months after VP shunt
Secondary Mini mental state Examination A score for cognitive ability; range 0-30; higher indicates higher severity. Change from Baseline at 6 months after VP shunt
Secondary Gait evaluation 10 meters walking test were evaluated of iNPH patients. Change from Baseline at 6 months after VP shunt
Secondary modified Rankin scale A score for functional neurological status ; range 0-5; higher indicates higher severity. Change from Baseline at 6 months after VP shunt
See also
  Status Clinical Trial Phase
Completed NCT00221091 - Study to Evaluate Efficacy of Shunt Operation for Idiopathic Normal Pressure Hydrocephalus Phase 2
Completed NCT01570257 - A Trial of High and Low Pressure Level Settings on a Programmable Ventriculoperitoneal Shunt Valve for Idiopathic Normal Pressure Hydrocephalus N/A
Recruiting NCT06428734 - Clinical Outcome in Patients With INPH
Completed NCT01319136 - Improved Analysis Methods for Infusion Tests N/A
Active, not recruiting NCT04795089 - Gait Pattern and Experienced Global Change After Shunt Surgery in Idiopathic Normal Pressure Hydrocephalus
Active, not recruiting NCT02495610 - Novel Parameters for the Prediction of Ventriculoperitoneal Shunting Efficacy in Patients With iNPH N/A
Completed NCT01374048 - Intracranial Pressure Waves Via Lumbar Puncture N/A